| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af5978c465dc99fa57524ae217ad798f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43fec27ff4153362aae3496ae6ef1c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B90-00 |
| filingDate |
2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08ae2fee9f2b4b19598508a834f67b3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012c69d53f703d0aec6f6e7f6a46be43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798289a7ed76b45cd1789fe1619a3934
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14376b83a5814ebfebe2ae4831788984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d4706a648e5bc88223f276681cd022 |
| publicationDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112674861-A |
| titleOfInvention |
System and method for determining lesion depth using fluorescence imaging |
| abstract |
The present invention relates to a system and method for determining lesion depth using fluorescence imaging. Systems, catheters, and methods are provided for treating Atrial Fibrillation (AF) configured to irradiate cardiac tissue having a lesion site; obtaining mitochondrial Nicotinamide Adenine Dinucleotide Hydrogen (NADH) fluorescence intensity from the irradiated heart tissue along a first line across the lesion site; creating a 2-dimensional (2D) map of the depth of the lesion site along the first line based on the NADH fluorescence intensity; and determining from the 2D map a depth of the lesion site at a selected point along the first line, wherein a lower NADH fluorescence intensity corresponds to a greater depth in the lesion site and a higher NADH fluorescence intensity corresponds to non-ablated tissue. This process can be repeated to create a 3-dimensional map of the depth of the lesion. |
| priorityDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |